Arymar, Inc. – Trademark Portfolio

Entity Type: 03

Arymar, Inc. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include ARYMAR, NOVAFLOR, CALAMBRIN, DIGESPLEN, and ESCABICIN. The owner is based in Hialeah, FL.

2658 West 78 Street

Hialeah, FL 33016

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Arymar, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (15 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Arymar, Inc. have?

Arymar, Inc. has 15 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 abandoned, 5 cancelled.

What trademark classes does Arymar, Inc. file in?

Arymar, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Arymar, Inc.'s most well-known trademarks?

Arymar, Inc.'s registered trademark portfolio includes well-known marks such as ARYMAR, NOVAFLOR, CALAMBRIN, DIGESPLEN, and ESCABICIN. These are among 9 currently registered trademarks in the portfolio.

What is Arymar, Inc.'s trademark registration success rate?

Arymar, Inc. has a 60% trademark registration rate, with 9 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.